Search This Blog

Friday, December 20, 2013

Eli Lilly and Company and Boehringer Ingelheim announce new drug application filing in the U.S. for new insulin glargine product (NYSE:LLY)

Eli Lilly and Company and Boehringer Ingelheim announce new drug application filing in the U.S. for new insulin glargine product (NYSE:LLY)

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.